Vaccine Development

Print

email this

One of the goals of the Duke Human Vaccine Institute has been to develop the enabling technology for vaccines that can induce broadly protective immune responses to the human immunodeficiency virus, influenza, and tuberculosis.

Human Immunodeficiency Virus

Influenza

Tuberculosis